🇺🇸 FDA
Pipeline program

Kunxian capsule

KYS2021-03-02-9

Unknown small_molecule completed

Quick answer

Kunxian capsule for Diabetic Nephropathy is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Diabetic Nephropathy
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials